{"chief_complaint_en": ["Weakness"], "calc_type": "diagnostic_criteria", "content": {"about": {"evidence_based_medicine_en": "", "formula_en": "<p>The Revised McDonald Criteria also includes diagnosis of <b>Primary progressive multiple sclerosis (PPMS). Positive if:</b></p> <ul> <li>\u22651 year of disease progression (this can be determined either prospectively or retrospectively)</span></li> <li>Plus two of the following three criteria</span> <ul> <li>Brain dissemination in space ( \u22651 T2 bright lesions in \u22651 of juxtacortical, periventricular, infratentorial areas) </span></li> <li>Spinal cord dissemination in space (\u22652 T2 bright lesions)</span></li> <li>Positive CSF (oligoclonal bands and/or elevated IgG index)</span></li> </ul> </li> </ul>", "more_info_en": "", "references_list": {"Original/Primary Reference": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/11456302", "text": "McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121\u2013127"}], "Validation": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/16283615", "text": "Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria.\u201d Ann Neurol. 2005;58:840\u2013846."}, {"href": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084507/", "text": "Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Annals of Neurology. 2011;69(2):292-302. doi:10.1002/ana.22366."}], "Other References": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/23906114", "text": "Runia TF, Jafari N and Hintzen RQ. Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes. European Journal of Neurology, 2013; 20:1510\u20131516. doi: 10.1111/ene.12243"}]}}, "contributor": {"expert_name": []}, "creator": [{"name": "Dr. Christopher H. Polman", "qa_en": "", "creator_info": {"deceased": null, "about_en": " <p>Christopher H. Polman, MD, is a professor and head of the neurology department at Vrije University (VU) in the Netherlands. He was appointed to the executive board of VU Medical Center. Dr. Polman has published over 250 papers since 2005 with a primary research focus on multiple sclerosis (MS) diagnosis and treatment.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-christopher-h-polman.jpeg", "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Polman%20CH%5Bauth%5D"}}], "how_to_use": {"pearls_pitfalls_en": "<p>The 2010 Revised McDonald Criteria is seen as the gold standard of MS diagnosis, and uses MRI data to aid in diagnosis.</p>", "use_case_en": "", "why_use_en": ""}, "next_steps": {"advice_en": "", "critical_actions_en": "", "management_en": "<p><b>The 2010 McDonald Criteria for Diagnosis of MS</b></p> <div class='table-responsive'> <table class='table table-bordered table-hover'> <tbody> <tr> <th>Clinical Presentation</th> <th>Additional Data Needed for MS Diagnosis</th> </tr> <tr> <td>\u2219Two or more attacks<br/>\u2219Objective clinical evidence of 2 or more lesions with reasonable historical evidence of a prior attack </td> <td>None; clinical evidence will suffice<br />Additional evidence (eg, brain MRI) desirable, but must be consistent with MS</td> </tr> <tr> <td>\u2219Two or more attacks<br/>\u2219Objective clinical evidence of 1 lesion </td> <td>Dissemination in space demonstrated by MRI<br />OR<br />Await further clinical attack implicating a different site</td> </tr> <tr> <td> \u2219One attack<br/>\u2219Objective clinical evidence of 2 or more lesions </td> <td>Dissemination in time demonstrated by MRI<br />OR<br />second clinical attack</td> </tr> <tr> <td> \u2219One attack<br/>\u2219Objective clinical evidence of 1 lesion (clinically isolated syndrome) </td> <td>Dissemination in space demonstrated by MRI<br />OR<br />Await a second clinical attack implicating a different CNS site<br />AND<br />Dissemination in time, demonstrated by MRI or second clinical attack</td> </tr> <tr> <td> \u2219Insidious neurologic progression suggestive of MS </td> <td>One year of disease progression and dissemination in space <br />AND<br />One or more T2 lesions in brain, in regions characteristic of MS<br />AND<br />Two or more T2 focal lesions in spinal cord Positive CSF</td> </tr> <tr> <td colspan='2'>Notes: An attack is defined as a neurologic disturbance of the kind seen in MS.<br />It can be documented by subjective report or by objective observation, but it must last for at least 24 hours.<br /> Pseudoattacks and single paroxysmal episodes must be excluded.<br />To be considered separate attacks, at least 30 days must elapse between onset of one event and onset of another event.</td> </tr> </tbody> </table> </div>"}}, "disease_en": ["Multiple Sclerosis"], "favorite_id": 2198, "full_title_en": "Revised McDonald Criteria for Multiple Sclerosis Diagnosis", "input_schema": [{"type": "subheading", "subheading": "Primary Criteria", "subheading_instructions": ""}, {"default": 0, "label_en": "\u22652 attacks", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "show_points": false, "tips_en": "Per Polman, et. al, 2010: \u201cAn attack is defined as a neurologic disturbance of the kind seen in MS. It can be documented by subjective report or by objective observation, but it must last for at least 24 hours. Pseudoattacks and single paroxysmal episodes must be excluded. To be considered separate attacks, at least 30 days must elapse between onset of one event and onset of another event.\u201d", "type": "toggle", "name": "attacks", "optional": false}, {"default": 0, "label_en": "Objective clinical evidence of \u22652 lesions on MRI", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "show_points": false, "type": "toggle", "name": "lesions", "optional": false}, {"default": 0, "label_en": "Objective clinical evidence of 1 lesion with reasonable historical evidence of a prior attack", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "show_points": false, "tips_en": "Per Polman, et. al, 2010: \u201cClinical diagnosis based on objective clinical findings for 2 attacks is most secure. Reasonable historical evidence for 1 past attack, in the absence of documented objective neurological findings, can include historical events with symptoms and evolution characteristics for prior inflammatory demyelinating even; at least 1 attack however must be supported by objective findings.\u201d", "type": "toggle", "name": "both", "optional": false}, {"conditionality": "lesions==0 && attacks==0 && both==0", "default": 0, "label_en": "<b>If none of these apply, click here to continue to additional criteria</b>", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "show_points": false, "type": "toggle", "name": "none", "optional": false}, {"type": "subheading", "subheading": "Dissemination in Space", "subheading_instructions": "Demonstrated by \u22651 T2 lesion in at least 2 of the following 4 CNS Regions)"}, {"conditionality": "none == 1", "default": 0, "label_en": "Periventricular", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "show_points": false, "type": "toggle", "name": "perivent", "optional": false}, {"conditionality": "none == 1", "default": 0, "label_en": "Juxtacordial", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "show_points": false, "type": "toggle", "name": "juxta", "optional": false}, {"conditionality": "none == 1", "default": 0, "label_en": "Infratentorial", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "show_points": false, "type": "toggle", "name": "infra", "optional": false}, {"conditionality": "none == 1", "default": 0, "label_en": "Spinal Cord", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "show_points": false, "type": "toggle", "name": "spine", "optional": false}, {"type": "subheading", "subheading": "Dissemination in Time", "subheading_instructions": "Demonstrated by \u22651 of the following:"}, {"conditionality": "none == 1", "default": 0, "label_en": "A new T2 and/or gadolinium-enhancing lesion(s) on follow-up MRI, with reference to a baseline scan, irrespective of the timing of baseline scan.", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "show_points": false, "type": "toggle", "name": "t2", "optional": false}, {"conditionality": "none == 1", "default": 0, "label_en": "Simultaneous presence of asymptomatic gadolinium-enhancing and nonenhancing lesions at any time.", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "show_points": false, "type": "toggle", "name": "simultaneous", "optional": false}, {"type": "subheading", "subheading": "Primary Progressive Multiple Sclerosis (PPMS) Criteria", "subheading_instructions": ""}, {"conditionality": "none == 1", "default": 0, "label_en": "One year of disease progression (retrospective or prospective)", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "show_points": false, "type": "toggle", "name": "prog", "optional": false}, {"conditionality": "none == 1", "default": 0, "label_en": "Evidence of dissemination in space in the spinal cord", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "show_points": false, "tips_en": "Based on \u22652 T2 lesions in the spinal cord", "type": "toggle", "name": "disspine", "optional": false}, {"conditionality": "none == 1", "default": 0, "label_en": "Positive CSF", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "show_points": false, "tips_en": "Isoelectric focusing evidence of oligoclonal bands and/or elevated IgG index", "type": "toggle", "name": "csf", "optional": false}], "instructions_en": "", "medium_description_en": "Determines presence of MS using MRI findings.", "purpose_en": ["Diagnosis"], "search_abbreviation_en": ["MS", "Mcdonald", "MRI", "dissemination", "time", "space"], "seo": {"meta_description_en": "The Revised McDonald Criteria for Multiple Sclerosis (MS) Diagnosis determines presence of MS using MRI findings.", "keywords_en": "ms criteria, mcdonald criteria, revised mcdonald criteria, r mcdonald, MRI ms diagnosis, mri ms, MS diagnosis criteria, ms diagnostic criteria, mcdonald revised, mcdonald diagnostic criteria, ms attack, psudoattack ms, clinical diagnosis ms, multiple sclerosis dx"}, "short_description_en": "Diagnose MS from MRI findings.", "short_title_en": "Revised McDonald Criteria", "slug": "revised-mcdonald-criteria-multiple-sclerosis-diagnosis", "specialty_en": ["Neurology", "Radiology"], "system_en": ["Neurologic"], "dosing": false, "before_use": "", "md5": "b10d4d102694b01e5795c9b0be3c013f", "related_calcs": [{"calcId": 10162, "short_title_en": "McDonald Criteria (2017 Revision)", "slug": "mcdonald-criteria-multiple-sclerosis-2017-revision"}, {"calcId": 2146, "short_title_en": "EDSS/FSS for Multiple Sclerosis", "slug": "expanded-disability-status-scale-edss-functional-systems-score-fss"}, {"calcId": 2197, "short_title_en": "Shortened Modified Fatigue Impact Scale", "slug": "shortened-modified-fatigue-impact-scale-mfis"}]}